OCS logo

Oculis Holding AG (OCS) EBITDA

annual EBITDA:

-$96.45M+$541.70K(+0.56%)
December 31, 2024

Summary

  • As of today (August 20, 2025), OCS annual EBITDA is -$96.45 million, with the most recent change of +$541.70 thousand (+0.56%) on December 31, 2024.
  • During the last 3 years, OCS annual EBITDA has fallen by -$82.04 million (-569.40%).
  • OCS annual EBITDA is now -657.71% below its all-time high of -$12.73 million, reached on December 1, 2020.

Performance

1-year change

+0.56%

3-year change

-569.4%

5-year change

-657.71%

15-year change

-657.71%

OCS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

18.51%
OCS annual EBITDA is higher than 18.51% of companies in Healthcare sector

Range

All-time high

-$12.73M

3-year low

-$96.99M

Earnings dates

Last annual earnings report date

Dec 31, 2024
OCS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
OCS next annual earnings announcement has not yet been scheduled

OtherOCSincome statement metrics

Annual revenue

$0.00
OCS annual revenue is $0.00

annual net income

-$97.40M
OCS annual net profit is -$97.40 million

annual EBIT

-$96.91M
OCS annual earnings before interest & taxes is -$96.91 million

Annual EPS

-$2.41
OCS annual earnings per share is -$2.41

quarterly EBITDA:

-$22.40M-$2.86M(-14.65%)
March 31, 2025

Summary

  • As of today (August 20, 2025), OCS quarterly EBITDA is -$22.40 million, with the most recent change of -$2.86 million (-14.65%) on March 31, 2025.
  • Over the past year, OCS quarterly EBITDA has dropped by -$4.74 million (-26.84%).
  • OCS quarterly EBITDA is now -9842.89% below its all-time high of $229.90 thousand, reached on September 30, 2022.

Performance

3-month change

-14.65%

1-year change

-26.84%

3-year change

-

5-year change

-20299.73%

OCS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

20.4%
OCS quarterly EBITDA is higher than 20.4% of companies in Healthcare sector

Range

All-time high

$229.90K
OCS quarterly EBITDA is currently -9842.89% below its historical high of $229.90 thousand

3-year low

-$25.03M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
OCS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 19, 2025
OCS next earnings announcement is scheduled for Aug 19, 2025

OtherOCSincome statement metrics

Quarterly revenue

$0.00
OCS quarterly revenue is $0.00

quarterly net income

-$36.95M
OCS quarterly net profit is -$36.95 million

quarterly EBIT

-$22.54M
OCS quarterly earnings before interest & taxes is -$22.54 million

Quarterly EPS

-$0.77
OCS quarterly earnings per share is -$0.77

TTM EBITDA:

-$88.00M-$4.74M(-5.69%)
March 31, 2025

Summary

  • As of today (August 20, 2025), OCS TTM EBITDA is -$88.00 million, with the most recent change of -$4.74 million (-5.69%) on March 31, 2025.
  • Over the past year, OCS TTM EBITDA has dropped by -$29.51 million (-50.45%).
  • OCS TTM EBITDA is now -19557.06% below its all-time high of $452.30 thousand, reached on March 31, 2023.

Performance

3-month change

-5.69%

1-year change

-50.45%

3-year change

-

5-year change

-80049.64%

OCS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

19.53%
OCS TTM EBITDA is higher than 19.53% of companies in Healthcare sector

Range

All-time high

$452.30K
OCS TTM EBITDA is currently <-9900.00% below its historical high of $452.30 thousand

3-year low

-$88.00M
OCS TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
OCS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 19, 2025
OCS next earnings announcement is scheduled for Aug 19, 2025

OtherOCSincome statement metrics

TTM revenue

$0.00
OCS TTM revenue is $0.00

TTM net income

-$115.95M
OCS TTM net profit is -$115.95 million

TTM EBIT

-$88.52M
OCS TTM earnings before interest & taxes is -$88.52 million

TTM EPS

-$2.65
OCS TTM earnings per share is -$2.65

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$96.45M
OCS annual EBITDA is -$96.45 million

annual net income

-$97.40M
OCS annual net profit is -$97.40 million

annual interest expense

$726.00K
OCS annual interest expense is $726.00 thousand

annual income tax

-$181.80K
OCS annual income tax is -$181.80 thousand

annual D&A

$461.30K
OCS annual depreciation & amortization is $461.30 thousand

OCS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.6%-26.8%-50.5%
3 y3 years-569.4%--
5 y5 years-657.7%-10000.0%-10000.0%

OCS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-569.4%+0.6%-9842.9%+10.5%<-9999.0%at low
5 y5-year-657.7%+0.6%-9842.9%+10.5%<-9999.0%at low
alltimeall time-657.7%+0.6%-9842.9%+10.5%<-9999.0%at low

OCS EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$22.40M(+14.7%)
-$88.00M(+5.7%)
Dec 2024
-$96.45M(-0.6%)
-$19.54M(-7.1%)
-$83.26M(+7.3%)
Sep 2024
-
-$21.04M(-16.0%)
-$77.59M(+8.7%)
Jun 2024
-
-$25.03M(+41.8%)
-$71.38M(+22.0%)
Mar 2024
-
-$17.66M(+27.4%)
-$58.50M(+43.5%)
Dec 2023
-$96.99M
-$13.86M(-6.6%)
-$40.77M(+51.5%)
Sep 2023
-
-$14.83M(+22.1%)
-$26.91M(+127.1%)
Jun 2023
-
-$12.15M(<-9900.0%)
-$11.85M(-2719.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
$68.00K(-70.4%)
$452.30K(-387.2%)
Dec 2022
-$33.45M(+132.2%)
-
-
Sep 2022
-
$229.90K(+48.9%)
-$157.50K(-75.4%)
Jun 2022
-
$154.40K(-128.5%)
-$640.70K(-41.7%)
Dec 2021
-$14.41M(+13.2%)
-$541.80K(+113.9%)
-$1.10M(+97.1%)
Sep 2021
-
-$253.30K(+30.0%)
-$557.90K(+83.2%)
Jun 2021
-
-$194.80K(+77.4%)
-$304.60K(+177.4%)
Mar 2021
-
-$109.80K
-$109.80K
Dec 2020
-$12.73M
-
-

FAQ

  • What is Oculis Holding AG annual EBITDA?
  • What is the all time high annual EBITDA for Oculis Holding AG?
  • What is Oculis Holding AG annual EBITDA year-on-year change?
  • What is Oculis Holding AG quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Oculis Holding AG?
  • What is Oculis Holding AG quarterly EBITDA year-on-year change?
  • What is Oculis Holding AG TTM EBITDA?
  • What is the all time high TTM EBITDA for Oculis Holding AG?
  • What is Oculis Holding AG TTM EBITDA year-on-year change?

What is Oculis Holding AG annual EBITDA?

The current annual EBITDA of OCS is -$96.45M

What is the all time high annual EBITDA for Oculis Holding AG?

Oculis Holding AG all-time high annual EBITDA is -$12.73M

What is Oculis Holding AG annual EBITDA year-on-year change?

Over the past year, OCS annual EBITDA has changed by +$541.70K (+0.56%)

What is Oculis Holding AG quarterly EBITDA?

The current quarterly EBITDA of OCS is -$22.40M

What is the all time high quarterly EBITDA for Oculis Holding AG?

Oculis Holding AG all-time high quarterly EBITDA is $229.90K

What is Oculis Holding AG quarterly EBITDA year-on-year change?

Over the past year, OCS quarterly EBITDA has changed by -$4.74M (-26.84%)

What is Oculis Holding AG TTM EBITDA?

The current TTM EBITDA of OCS is -$88.00M

What is the all time high TTM EBITDA for Oculis Holding AG?

Oculis Holding AG all-time high TTM EBITDA is $452.30K

What is Oculis Holding AG TTM EBITDA year-on-year change?

Over the past year, OCS TTM EBITDA has changed by -$29.51M (-50.45%)
On this page